Altogether, our comprehensive study shows that derailed activity of super-enhancers as a consequence of SMARCB1 loss underpins MRT tumorigenesis and serves as a blueprint for unraveling the contribution of BAF complex mutations to tumorigenesis across cancers. This evidence concerns the gene SMARCB1 and cancer.